Velocity’s research site in Columbia was founded in 2019 as part of VitaLink Research, and acquired by Velocity in 2021. Our Columbia site has extensive expertise in respiratory and vaccine trials. In recent years the site has worked to become more therapeutically diverse, with the addition of trials in Migraine and Alzheimer’s research. All trials are performed in accordance with ICH and FDA guidelines, and in compliance with GCP.
Conveniently located within a medical office on the campus of the local hospital and adjacent to the Principal Investigator’s pulmonary practice, our site staff excel in enrolling diverse patient populations for studies. Ample patient parking is also available in a shared lot monitored by hospital security. The Columbia team is committed to being a resource for study volunteers, to providing the highest quality of patient care with compassion and kindness and to advancing medicine through research.